Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 11 of 11 entries
View as:

VOICE-Early Response to Vedolizumab and IL-23 Antagonists in Participants With Crohn's Disease: A Prospective Observational Study

Phase: N/A Priority: Normal
NCT ID: NCT06249555 Org: User:
Start: 03/20/24 End: 12/31/26 Due: 12/31/27

Stopping Aminosalicylate Therapy in Inactive Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT03261206 Org: User:
Start: 11/20/17 End: 06/30/26 Due: 06/30/27

Development of a Novel Endoscopic Index and Patient-reported Outcome Measure for Clinical Trials in Participants with Permanent Ileostomy

Phase: N/A Priority: Normal
NCT ID: NCT06670638 Org: User:
Start: 12/02/24 End: 11/30/26 Due: 11/30/27

Open-label Single-arm Study to Assess the Efficacy of Mirikizumab in Patients With Inflammatory Strictures Due to CD

Phase: N/A Priority: Normal
NCT ID: NCT06997965 Org: User:
Start: 09/01/25 End: 04/01/28 Due: 04/01/29

Assessment of Patients With Acute Pouchitis Treated With Antibiotics

Phase: N/A Priority: Normal
NCT ID: NCT05252273 Org: User:
Start: 12/07/21 End: 12/09/24 Due: 12/09/25

Pharmacokinetics of Adalimumab With Methotrexate for Treatment of Patients With Ulcerative Colitis (UC)

Phase: N/A Priority: Normal
NCT ID: NCT01716039 Org: User:
Start: 06/30/13 End: 07/18/16 Due: 07/18/17

Pharmacokinetics of IFX and TNF Concentrations in Serum, Stool, and Colonic Mucosa in Acute Severe Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT03765450 Org: User:
Start: 12/21/18 End: 03/02/26 Due: 03/02/27

Identification of Biomarkers of Janus Kinase Inhibitor Therapy in Patients With Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT04576000 Org: User:
Start: 08/25/20 End: 12/02/21 Due: 12/02/22

Enhanced Algorithm for Crohn's Treatment Incorporating Early Combination Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01698307 Org: User:
Start: 03/28/14 End: 04/16/20 Due: 04/16/21

Determination of the Optimal Treatment Target in Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT04259138 Org: User:
Start: 02/18/20 End: 03/31/26 Due: 03/31/27

VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT06257706 Org: User:
Start: 08/07/24 End: 09/06/28 Due: 09/06/29